NLM Digital Collections

Search

Start Over Subjects Government Regulation ✖Remove constraint Subjects: Government Regulation Copyright Public domain ✖Remove constraint Copyright: Public domain Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

2. ACF cannot ensure that all child victims of abuse and neglect have court representation

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, March 2021
Subject(s):
Child Abuse -- legislation & jurisprudence
Child Protective Services -- standards
Government Regulation
Legal Services -- organization & administration
United States
United States. Department of Health and Human Services

4. Abuse and neglect: CMS should strengthen reporting requirements to better protect individuals receiving hospice care : report to the Honorable Charles E. Grassley, United States Senate

Publication:
Washington, DC : United States Government Accountability Office, December 2022
Subject(s):
Elder Abuse -- legislation & jurisprudence
Government Regulation
Hospice Care -- legislation & jurisprudence
Legislation, Medical
Mandatory Reporting
Medicaid -- organization & administration
Medicare -- organization & administration
United States
Centers for Medicare & Medicaid Services (U.S.)

12. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 2017
Subject(s):
Air Ambulances -- economics
Fees and Charges
Insurance Coverage -- economics
Cost Sharing
Data Collection
Disclosure
Government Regulation
Humans
United States
United States. Department of Transportation.
Centers for Medicare & Medicaid Services (U.S.)

14. Air travel and communicable diseases: status of research efforts and action still needed to develop federal preparedness plan : testimony before the Subcommittee on Space and Aeronautics, Committee on Science, Space, and Technology, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, June 23, 2020
Subject(s):
Air Travel
Communicable Diseases -- transmission
Disaster Planning -- legislation & jurisprudence
Government Regulation
Pandemics -- legislation & jurisprudence
Travel-Related Illness
COVID-19 -- transmission
United States

15. Alternative procedures for the manufacture of cold-stored platelets intended for the treatment of active bleeding when conventional platelets are not available or their use is not practical: guidance for industry

Publication:
Silver Spring, MD : Center for Biologics Evaluation and Research, June 2023
Subject(s):
Biological Products -- standards
Blood Platelets
Government Regulation
Platelet Transfusion
Refrigeration
United States

16. Animal use in research: NIH should strengthen oversight of projects it funds at foreign facilities : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, March 2023
Subject(s):
Animal Experimentation -- legislation & jurisprudence
Animal Experimentation -- standards
Government Regulation
International Cooperation -- legislation & jurisprudence
Legislation, Medical
Research -- economics
United States

18. Antibiotic resistance: Federal agencies have taken steps to combat the threat, but additional actions needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, April 28, 2023
Subject(s):
Drug Resistance, Microbial
Government Regulation
Legislation, Medical
United States
United States. Department of Health and Human Services

24. Artificial intelligence in health care: benefits and challenges of machine learning technologies for medical diagnostics : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2022
Subject(s):
Artificial Intelligence -- legislation & jurisprudence
Diagnosis, Computer-Assisted -- legislation & jurisprudence
Government Regulation
Health Policy
Legislation, Medical
United States

27. Behavioral health and COVID-19: higher-risk populations and related federal relief funding : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, December 2021
Subject(s):
COVID-19 -- psychology
Government Regulation
Mental Health Services -- legislation & jurisprudence
Pandemics -- economics
Vulnerable Populations -- legislation & jurisprudence
United States

28. Behavioral health: Available workforce information and federal actions to help recruit and retain providers : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2022
Subject(s):
Behavioral Medicine -- organization & administration
Behavioral Medicine -- statistics & numerical data
Government Regulation
Health Personnel
Health Workforce -- organization & administration
Health Workforce -- statistics & numerical data
Legislation, Medical
Mental Health Services
Personnel Selection -- organization & administration
Personnel Selection -- statistics & numerical data
United States
United States. Department of Health and Human Services

31. Billions in estimated Medicare Advantage payments from diagnoses reported only on health risk assessments raise concerns

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):
Fraud -- prevention & control
Government Regulation
Medicare Part C -- economics
Risk Adjustment -- economics
United States
United States. Department of Health and Human Services

33. Black Lung Benefits Program: oversight is needed to address trust fund solvency strained by bankruptcies : testimony before the Committee on Education and Labor, Subcommittee on Workforce Protections, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, February 26, 2020
Subject(s):
Anthracosis -- economics
Bankruptcy -- economics
Coal Mining -- legislation & jurisprudence
Government Regulation
United States

34. Black Lung benefits program: continued inaction on coal operator self-insurance increases financial risk to trust fund : testimony before the Committee on Education and Labor, Subcommittee on Workforce Protections, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, December 2, 2021
Subject(s):
Anthracosis -- economics
Government Regulation
Insurance, Health -- legislation & jurisprudence
United States

36. Bureau of Prisons: assessment of health care reentry policies and procedures needed : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, February 2023
Subject(s):
Government Regulation
Legislation, Medical
Medicaid -- organization & administration
Prisoners -- legislation & jurisprudence
Prisons -- organization & administration
Transitional Care -- legislation & jurisprudence
United States
United States. Bureau of Prisons

37. CARES Act: experts identified safeguards to help selected HHS agencies protect against potential political interference : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
Government Regulation
Legislation, Medical
Politics
Professional Misconduct
United States
United States.
United States. Department of Health and Human Services

38. CDC generally met its inspection goals for the federal select agent program: however, opportunities exist to strengthen oversight

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, May 2017
Subject(s):
Government Regulation
Security Measures
Toxins, Biological
Federal Government
Laboratories -- standards
Risk Assessment
Risk Management
Humans
United States
United States. Department of Health and Human Services.
Centers for Disease Control and Prevention (U.S.)

40. CDC provided oversight and assistance: however, ELC recipients still faced challenges in implementing COVID-19 screening testing programs

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
COVID-19 Testing -- instrumentation
Government Programs
Government Regulation
United States
Centers for Disease Control and Prevention (U.S.)

41. CDC’S Vaccines for Children program recipients did not conduct site visits at some providers as required

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
Child Health
Government Programs
Government Regulation
Immunization Programs
Vaccines -- supply & distribution
United States
Centers for Disease Control and Prevention (U.S.)
Vaccines for Children (Program)

44. CMS can do more to leverage Medicare claims data to identify unreported incidents of potential abuse or neglect

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):
Child Abuse -- legislation & jurisprudence
Elder Abuse -- legislation & jurisprudence
Government Regulation
Medicare -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

45. CMS could improve the data it uses to monitor antipsychotic drugs in nursing homes

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2021
Subject(s):
Antipsychotic Agents -- standards
Frail Elderly -- statistics & numerical data
Government Regulation
Nursing Homes -- legislation & jurisprudence
Vulnerable Populations -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

46. CMS has opportunities to strengthen states’ oversight of Medicaid Managed Care Plans’ reporting of medical loss ratios

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):
Government Regulation
Managed Care Programs -- organization & administration
Medicaid
State Health Planning and Development Agencies
United States
Centers for Medicare & Medicaid Services (U.S.)

48. CMS should pursue strategies to increase the number of at-risk beneficiaries acquiring naloxone through Medicaid

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):
Government Regulation
Medicaid -- economics
Naloxone -- supply & distribution
Opioid-Related Disorders -- economics
United States
United States. Department of Health and Human Services

49. CMS should take further action to address states with poor performance in conducting nursing home surveys

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, January 2022
Subject(s):
Government Regulation
Health Care Surveys -- standards
Nursing Homes -- legislation & jurisprudence
Public Reporting of Healthcare Data
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

50. CMS use of data on nursing home staffing: progress and opportunities to do more

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, March 2021
Subject(s):
Government Regulation
Health Workforce -- legislation & jurisprudence
Nursing Homes -- standards
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

51. CMS’s encounter data lack essential information that Medicare Advantage organizations have the ability to collect

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, August 2020
Subject(s):
Data Management -- legislation & jurisprudence
Fraud -- prevention & control
Government Regulation
Medicare Part C -- organization & administration
Records -- statistics & numerical data
United States
United States. Department of Health and Human Services

52. COVID-19 Provider Relief Fund: HRSA continues to recover remaining payments due from providers : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
COVID-19
Disaster Planning -- economics
Disaster Planning -- organization & administration
Fraud -- prevention & control
Government Regulation
Health Personnel -- economics
Legislation, Medical
United States
United States. Health Resources and Services Administration

53. COVID-19 contracting: Indian Health Service used flexibilities to meet increased medical supply needs : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, October 2021
Subject(s):
American Indians or Alaska Natives -- statistics & numerical data
COVID-19 -- ethnology
Equipment and Supplies -- supply & distribution
Government Regulation
United States
United States. Indian Health Service

54. COVID-19 in nursing homes: CMS needs to continue to strengthen oversight of infection prevention and control : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, September 2022
Subject(s):
COVID-19
Government Regulation
Infection Control -- legislation & jurisprudence
Legislation, Medical
Nursing Homes -- standards
United States
Centers for Medicare & Medicaid Services (U.S.)

55. COVID-19 in nursing homes: Experts identified actions aimed at improving infection prevention and control : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, March 2023
Subject(s):
COVID-19 -- prevention & control
Cross Infection -- prevention & control
Hand Hygiene -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Nursing Homes -- legislation & jurisprudence
United States

59. COVID-19 pandemic: actions needed to improve federal oversight of assistance to individuals, communities, and the transportation industry : testimony before the Committee on Transportation and Infrastructure, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, July 29, 2021
Subject(s):
COVID-19 -- economics
Disasters -- economics
Government Regulation
United States

60. COVID-19 tests drove an increase in total Medicare Part B spending on lab tests in 2020, while use of non-COVID-19 tests decreased significantly

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2021
Subject(s):
Clinical Laboratory Techniques -- economics
COVID-19 Testing -- economics
Government Regulation
Medicare Part B -- economics
United States
United States. Department of Health and Human Services

63. COVID-19: Current and future federal preparedness requires fixes to improve health data and address improper payments : report to congressional committees

Publication:
[Washington, DC] : United States Government Accountability Office, April 2022
Subject(s):
COVID-19 -- economics
Fraud -- legislation & jurisprudence
Government Regulation
Pandemics -- legislation & jurisprudence
Routinely Collected Health Data
United States

68. COVID-19: HHS and DOD transitioned vaccine responsibilities to HHS, but need to address outstanding issues : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, January 2022
Subject(s):
COVID-19 Vaccines -- supply & distribution
Government Regulation
Health Workforce -- legislation & jurisprudence
United States
United States. Department of Defense
United States. Department of Health and Human Services

69. COVID-19: HHS funds allocated to support disproportionately affected communities : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, January 2023
Subject(s):
COVID-19 -- economics
Disaster Planning -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Pandemics -- economics
Arizona
Louisiana
Michigan
New Hampshire
Washington
United States. Department of Health and Human Services

72. COVID-19: Information on HHS's public education campaign : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, March 2022
Subject(s):
Education, Public Health Professional
Financial Management -- organization & administration
Government Regulation
Health Promotion -- organization & administration
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
National Institutes of Health (U.S.)

73. COVID-19: Pandemic lessons highlight need for public health situational awareness network : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, June 2022
Subject(s):
Awareness
Civil Defense -- organization & administration
COVID-19
Government Regulation
Pandemics -- legislation & jurisprudence
United States
United States. Department of Health and Human Services

74. COVID-19: Selected states modified meal provision and other Older Americans Act services to prioritize safety : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, December 2021
Subject(s):
Food Services -- economics
Health Services for the Aged -- economics
Home Care Services -- organization & administration
Government Regulation
COVID-19
United States
United States.

76. COVID-19: USAID plans to share lessons learned from efforts to meet global vaccination goal : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
COVID-19 Vaccines -- supply & distribution
Global Health
Government Regulation
Immunization Programs
International Cooperation
Legislation, Medical
United States
United States. Agency for International Development

77. COVID-19: VA should assess its oversight of infection prevention and control in community living centers : report to Congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, July 2021
Subject(s):
Communicable Disease Control -- legislation & jurisprudence
COVID-19 -- economics
Government Regulation
Nursing Homes -- legislation & jurisprudence
United States
United States. Department of Veterans Affairs

82. COVID-19: implementation and oversight of preparedness strategies at Veterans Affairs medical centers : report to Congressional addresses

Publication:
Washington, DC : United States Government Accountability Office, June 2021
Subject(s):
Civil Defense -- legislation & jurisprudence
COVID-19 -- prevention & control
Disaster Planning -- legislation & jurisprudence
Government Regulation
United States
United States. Department of Veterans Affairs

88. Case study: Missouri’s efforts to protect children missing from foster care

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2021
Subject(s):
Child, Foster -- legislation & jurisprudence
Foster Home Care -- legislation & jurisprudence
Government Regulation
Homeless Youth -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
Missouri
United States
United States. Department of Health and Human Services

89. Certain Medicare beneficiaries, such as urban and Hispanic beneficiaries, were more likely than others to use telehealth during the first year of the COVID-19 pandemic

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):
COVID-19
Government Regulation
Hispanic or Latino
Medicare
Telemedicine -- statistics & numerical data
Urban Population
United States

91. Characteristics of separated children in ORR’s care: June 27, 2018–November 15, 2020

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, November 2021
Subject(s):
Child Health -- legislation & jurisprudence
Government Regulation
Refugees -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
United States
United States. Department of Health and Human Services

98. Clinical labs: studies suggest biopsy specimen misidentification and contamination errors are infrequent : report to the Ranking Member, Committee on Finance, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, November 2020
Subject(s):
Clinical Laboratory Techniques -- standards
Diagnostic Errors -- legislation & jurisprudence
Government Regulation
Specimen Handling -- standards
United States
Centers for Medicare & Medicaid Services (U.S.)

99. Coast Guard health care: Additional actions could help ensure beneficiaries’ access : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, April 2023
Subject(s):
Dental Health Services -- statistics & numerical data
Government Regulation
Health Services Accessibility -- statistics & numerical data
Legislation, Medical
Military Personnel -- legislation & jurisprudence
National Health Insurance, United States -- legislation & jurisprudence
United States

100. Coast Guard health care: improvements needed for determining staffing needs and monitoring access to care : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, February 2022
Subject(s):
Government Regulation
Health Workforce -- statistics & numerical data
Military Health Services -- standards
Military Personnel -- statistics & numerical data
United States
United States. Department of Homeland Security

Refine by:

more »

more »

more »

Current results range from 2006 to 2024